Anticancer Peptidylarginine Deiminase (PAD) Inhibitors Regulate the Autophagy Flux and the Mammalian Target of Rapamycin Complex 1 Activity
Open Access
- 1 July 2012
- journal article
- research article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 287 (31), 25941-25953
- https://doi.org/10.1074/jbc.m112.375725
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- Synthesis and Screening of a Haloacetamidine Containing Library To Identify PAD4 Selective InhibitorsACS Chemical Biology, 2011
- Regulation of mouse oocyte microtubule and organelle dynamics by PADI6 and the cytoplasmic latticesDevelopmental Biology, 2011
- Investigating the Pathogenic Role of PADI4 in Oesophageal CancerInternational Journal of Biological Sciences, 2011
- {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM): Its anti-cancer efficacy and intercalation mechanism identified via multi-model systemsMolecular BioSystems, 2010
- Stimulation of autophagy by the p53 target gene Sestrin2Cell Cycle, 2009
- Neutral loss of isocyanic acid in peptide CID spectra: A novel diagnostic marker for mass spectrometric identification of protein citrullinationJournal of the American Society for Mass Spectrometry, 2008
- Epigenetic therapy of cancer: past, present and futureNature Reviews Drug Discovery, 2006
- Regulation of coactivator complex assembly and function by protein arginine methylation and demethyliminationProceedings of the National Academy of Sciences of the United States of America, 2005
- Human PAD4 Regulates Histone Arginine Methylation Levels via DemethyliminationScience, 2004
- Immunologic and genetic characterization of S180, a cell line of murine origin capable of growing in different inbred strains of miceVeterinary Immunology and Immunopathology, 1992